David M. Johnson - Oct 3, 2023 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder, Attorney-in-fact
Stock symbol
AURA
Transactions as of
Oct 3, 2023
Transactions value $
$168,175
Form type
4
Date filed
10/5/2023, 07:56 PM
Previous filing
Jun 16, 2023
Next filing
Nov 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Purchase $112K +13.5K +45% $8.27 43.5K Oct 3, 2023 Direct F1
transaction AURA Common Stock Purchase $56.5K +6.57K +15.09% $8.61 50.1K Oct 4, 2023 Direct F2
holding AURA Common Stock 140K Oct 3, 2023 By Velocity Capital Management F3
holding AURA Common Stock 18K Oct 3, 2023 By NEJ09 IRREVOCABLE TRUST F4
holding AURA Common Stock 18K Oct 3, 2023 By NEJ12 IRREVOCABLE TRUST F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.00 to $8.51, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.52 to $8.66, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F3 Velosity Capital Management LLC is an entity that the reporting person is the sole member of.
F4 The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F5 The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.